5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.02%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.03%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.95%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.95%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
120.00%
Net income growth comparable to METSB.HE's 120.00%. Walter Schloss might see both following similar market or cost trajectories.
200.00%
EPS growth similar to METSB.HE's 200.00%. Walter Schloss would assume both have parallel share structures and profit trends.
200.00%
Similar diluted EPS growth to METSB.HE's 200.00%. Walter Schloss might see standard sector or cyclical influences on both firms.
-26.67%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-26.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
5272.73%
Similar dividend growth to METSB.HE's 5272.73%. Walter Schloss might see parallel free cash flow or payout philosophies.
-108.37%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-148.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-2.89%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-2.89%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-32.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
79.10%
10Y OCF/share CAGR in line with METSB.HE's 79.10%. Walter Schloss would see both as similarly efficient over the decade.
79.10%
5Y OCF/share CAGR is similar to METSB.HE's 79.10%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
84.71%
3Y OCF/share CAGR similar to METSB.HE's 84.71%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
120.93%
Similar net income/share CAGR to METSB.HE's 120.93%. Walter Schloss would see parallel tailwinds or expansions for both firms.
120.93%
5Y net income/share CAGR similar to METSB.HE's 120.93%. Walter Schloss might see both on parallel mid-term trajectories.
300.00%
3Y net income/share CAGR similar to METSB.HE's 300.00%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.04%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.87%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.86%
Inventory growth well above METSB.HE's 4.86%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.06%
Similar asset growth to METSB.HE's 0.06%. Walter Schloss finds parallel expansions or investment rates.
32.93%
Similar to METSB.HE's 32.93%. Walter Schloss finds parallel capital usage or profit distribution strategies.
3.44%
Debt growth far above METSB.HE's 3.44%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
5.39%
SG&A growth well above METSB.HE's 5.39%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.